Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
86.16
+0.07 (0.08%)
Aug 1, 2025, 4:00 PM - Market closed
CTI BioPharma Market Cap
Glaukos has a market cap or net worth of $4.93 billion as of August 1, 2025. Its market cap has decreased by -22.08% in one year.
Market Cap
4.93B
Enterprise Value
4.76B
1-Year Change
-22.08%
Ranking
Category
Stock Price
$86.16
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $4.93B, an increase of 393.45%. That is a compound annual growth rate of 17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 4.92B | -40.50% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
| Jun 25, 2015 | 999.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.24B |
| Johnson & Johnson | 400.70B |
| AbbVie | 343.23B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 229.56B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.33B |
| Novo Nordisk | 221.96B |